Roche has a strong R&D presence in the U.S., since acquiring one of the biotech pioneers, Genentech back in 2009, and Roche’s acquisition of Ventana in 2008 bolstered its diagnostics group.

BOSTON (CBS) - The first time I saw Kevin Youkilis was in Spring Training back in either 2002 or 2003. He stood out because he didn't really have that "baseball body" that nearly all players have ...

Her mother is Suzzy Roche — one third of the harmonious Roche sisters. Her half-brother and -sister are Rufus and Martha Wainwright, each acclaimed singer-songwriters in their own right.

Swiss drugmaker Roche Holdings (NASDAQOTH: RHHBY) got a nod from the FDA for its multiple sclerosis drug Ocrevus at the end of March, triggering hope. Roche Just Scored One of the Biggest Pharma ...

BOSTON (CBS) - It seems like it happens every season at this same time. Early September, and for some reason it seems to happen when the Red Sox are in Toronto. Sox fans wake up this morning to ...

Roche’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints ...

Results from the Phase III study showed that subcutaneous (SC) injection was consistent with IV infusion and demonstrated near-complete suppression of relapse activity (97%) and MRI lesions (97.2% ...

Swiss drugmaker Roche said its new one-dose flu medicine Xofluza was comparable to its 20-year-old drug Tamiflu in reducing the duration of symptoms of the viral disease, citing a study of the ...

Extending treatment with Roche's breast cancer drug Herceptin to two years from the one year current standard is not worth while, trial data showed on Monday, but shortening treatment to six ...

In February 2021, Roche Freedman fired one of its partners, Jason Cyrulnik. He hit back with a lawsuit that disclosed each partner’s share of the AVAX tokens. That fall, Kleiman v.

Look around. Is there any competition behind you? Ok, whew. The coast is clear to try to get a great acquisition on the cheap. At least, that is the picture analysts paint of Roche Holdings' offer ...